1. Home
  2. PRME vs BLND Comparison

PRME vs BLND Comparison

Compare PRME & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • BLND
  • Stock Information
  • Founded
  • PRME 2019
  • BLND 2012
  • Country
  • PRME United States
  • BLND United States
  • Employees
  • PRME N/A
  • BLND N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • BLND EDP Services
  • Sector
  • PRME Health Care
  • BLND Technology
  • Exchange
  • PRME Nasdaq
  • BLND Nasdaq
  • Market Cap
  • PRME 588.2M
  • BLND 625.9M
  • IPO Year
  • PRME 2022
  • BLND 2021
  • Fundamental
  • Price
  • PRME $4.09
  • BLND $3.57
  • Analyst Decision
  • PRME Strong Buy
  • BLND Buy
  • Analyst Count
  • PRME 9
  • BLND 6
  • Target Price
  • PRME $14.75
  • BLND $3.58
  • AVG Volume (30 Days)
  • PRME 525.2K
  • BLND 3.5M
  • Earning Date
  • PRME 11-01-2024
  • BLND 11-05-2024
  • Dividend Yield
  • PRME N/A
  • BLND N/A
  • EPS Growth
  • PRME N/A
  • BLND N/A
  • EPS
  • PRME N/A
  • BLND N/A
  • Revenue
  • PRME $591,000.00
  • BLND $152,122,000.00
  • Revenue This Year
  • PRME N/A
  • BLND $4.74
  • Revenue Next Year
  • PRME N/A
  • BLND $25.20
  • P/E Ratio
  • PRME N/A
  • BLND N/A
  • Revenue Growth
  • PRME N/A
  • BLND N/A
  • 52 Week Low
  • PRME $3.47
  • BLND $1.10
  • 52 Week High
  • PRME $12.66
  • BLND $4.22
  • Technical
  • Relative Strength Index (RSI)
  • PRME 46.07
  • BLND 52.06
  • Support Level
  • PRME $3.47
  • BLND $3.26
  • Resistance Level
  • PRME $4.40
  • BLND $3.62
  • Average True Range (ATR)
  • PRME 0.28
  • BLND 0.22
  • MACD
  • PRME 0.05
  • BLND -0.06
  • Stochastic Oscillator
  • PRME 53.75
  • BLND 36.31

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

Share on Social Networks: